506 related articles for article (PubMed ID: 18035584)
41. Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study.
Alpsoy E; Donmez L; Onder M; Gunasti S; Usta A; Karincaoglu Y; Kandi B; Buyukkara S; Keseroglu O; Uzun S; Tursen U; Seyhan M; Akman A
Br J Dermatol; 2007 Nov; 157(5):901-6. PubMed ID: 17711526
[TBL] [Abstract][Full Text] [Related]
42. [Uveitis in Behçet's Syndrome in Germany - Prognosis During Current Therapy].
Stübiger N; Deuter C; Doycheva D
Klin Monbl Augenheilkd; 2020 May; 237(5):591-598. PubMed ID: 32434242
[TBL] [Abstract][Full Text] [Related]
43. Visual evoked potential findings in Behcet's disease without neurological manifestations.
Anlar O; Akdeniz N; Tombul T; Calka O; Bilgili SG
Int J Neurosci; 2006 Mar; 116(3):281-7. PubMed ID: 16484054
[TBL] [Abstract][Full Text] [Related]
44. Behçet's disease in Western Switzerland: epidemiology and analysis of ocular involvement.
Ambresin A; Tran T; Spertini F; Herbort C
Ocul Immunol Inflamm; 2002 Mar; 10(1):53-63. PubMed ID: 12461704
[TBL] [Abstract][Full Text] [Related]
45. Immunopathogenesis of Behçet's disease and treatment modalities.
van der Houwen TB; van Hagen PM; van Laar JAM
Semin Arthritis Rheum; 2022 Feb; 52():151956. PubMed ID: 35038644
[TBL] [Abstract][Full Text] [Related]
46. [A clinical analysis of ocular involvement in 111 cases of Behcet's disease].
Wu H; Li G; Chen H; Zheng W; Zhang M; Zhao Y
Zhonghua Nei Ke Za Zhi; 2014 Jan; 53(1):44-7. PubMed ID: 24674728
[TBL] [Abstract][Full Text] [Related]
47. Immunopathogenesis of Behcet's Disease.
Tong B; Liu X; Xiao J; Su G
Front Immunol; 2019; 10():665. PubMed ID: 30984205
[TBL] [Abstract][Full Text] [Related]
48. [Characteristics of ocular involvement in Behçet disease in Tunisia: Monocentric study and review of literature].
Ajili F; Bellakhal S; Ben Abdelhafidh N; Mrabet A; Zouari B; Maalej A; Louzir B; Laabidi J; Othmani S
Pathol Biol (Paris); 2015 Apr; 63(2):85-90. PubMed ID: 25434793
[TBL] [Abstract][Full Text] [Related]
49. Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study.
Salvarani C; Pipitone N; Catanoso MG; Cimino L; Tumiati B; Macchioni P; Bajocchi G; Olivieri I; Boiardi L
Arthritis Rheum; 2007 Feb; 57(1):171-8. PubMed ID: 17266063
[TBL] [Abstract][Full Text] [Related]
50. [Behçet's disease].
Brand HS; van Beusichem FF; van Nieuw Amerongen A
Ned Tijdschr Tandheelkd; 2008 Jun; 115(6):340-5. PubMed ID: 18618988
[TBL] [Abstract][Full Text] [Related]
51. Relationship between periodontal findings and the TNF-alpha Gene 1031T/C polymorphism in Turkish patients with Behçet's disease.
Akman A; Sallakci N; Kacaroglu H; Tosun O; Yavuzer U; Alpsoy E; Yegin O
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):950-7. PubMed ID: 18355201
[TBL] [Abstract][Full Text] [Related]
52. A histopathological approach: when papulopustular lesions should be in the diagnostic criteria of Behçet's disease?
Kalkan G; Karadag AS; Astarci HM; Akbay G; Ustun H; Eksioglu M
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1056-60. PubMed ID: 19453803
[TBL] [Abstract][Full Text] [Related]
53. Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.
Sota J; Rigante D; Lopalco G; Frediani B; Franceschini R; Galeazzi M; Iannone F; Tosi GM; Fabiani C; Cantarini L
Rheumatol Int; 2018 Jan; 38(1):25-35. PubMed ID: 28752230
[TBL] [Abstract][Full Text] [Related]
54. Genetic and non-genetic factors affecting the visual outcome of ocular Behcet's disease.
Kang EH; Park JW; Park C; Yu HG; Lee EB; Park MH; Song YW
Hum Immunol; 2013 Oct; 74(10):1363-7. PubMed ID: 23831258
[TBL] [Abstract][Full Text] [Related]
55. Chromosome and sister chromatid exchange studies in Behcet's patients.
Oztas S; Gullulu G; Tatar A; Astam N; Akyol I; Karakuzu A; Aktas A; Odabas AR
J Dermatol; 2006 Jun; 33(6):406-10. PubMed ID: 16700831
[TBL] [Abstract][Full Text] [Related]
56. The management of Behçet's syndrome.
Fresko I; Yurdakul S; Hamuryudan V; Ozyazgan Y; Mat C; Tanverdi MM; Yazici H
Ann Med Interne (Paris); 1999 Nov; 150(7):576-81. PubMed ID: 10637674
[TBL] [Abstract][Full Text] [Related]
57. [Behcet's disease].
Ríhová E; Havlíková M; Michalová K; Rothová Z; Poch T
Cesk Slov Oftalmol; 1997 Oct; 53(5):298-304. PubMed ID: 9508495
[TBL] [Abstract][Full Text] [Related]
58. Clinical and demographic evaluation of Behçet disease among different paediatric age groups.
Sungur GK; Hazirolan D; Yalvac I; Ozer PA; Yuksel D; Vural ET; Duman S
Br J Ophthalmol; 2009 Jan; 93(1):83-7. PubMed ID: 18952648
[TBL] [Abstract][Full Text] [Related]
59. Cyclosporin A in the treatment of posterior uveitis.
Graham EM; Sanders MD; James DG; Hamblin A; Kasp Grochowska E; Dumonde D
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():146-51. PubMed ID: 3857775
[TBL] [Abstract][Full Text] [Related]
60. [Treatment of Behçet's disease].
Comarmond C; Wechsler B; Cacoub P; Saadoun D
Rev Med Interne; 2014 Feb; 35(2):126-38. PubMed ID: 24438860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
